"Bloodless Treatment Strategies in Acute Chest Syndrome in Jehovah's Wi" by Juan Martinez Ortega, Ammar Vohra et al.
 

Bloodless Treatment Strategies in Acute Chest Syndrome in Jehovah's Witnesses: A Case Report

Document Type

Article

Publication Date

10-2024

Publication Title

Chest Journal

Abstract

Acute chest syndrome (ACS) is a severe sickle cell disease (SCD) complication characterized by pulmonary inflammation and vascular occlusion. It is the second most common cause of hospitalization and the leading cause of admission to intensive care units and premature death. Up to 20% of the patients admitted for vaso-occlusive crisis will develop ACS in the first three days. The mainstay of treatment comprises hydration, antibiotics, analgesics, and blood transfusion. Management of ACS in Jehovah's Witnesses (JW) presents unique challenges due to their religious beliefs against blood transfusion. Consequently, alternative strategies and meticulous shared decision-making are necessary to optimize its outcomes. This case report highlights the complexities of managing ACS in a JW patient with SCD and underscores the importance of individualized care strategies tailored to personal and religious considerations.

Volume

166

Issue

4 Supplement

First Page

A2541

Last Page

A2542

DOI

10.1016/j.chest.2024.06.1546

This document is currently not available here.

Find in My Library

Share

COinS